Signed Into Law
Signed June 20, 2025Effective 2025-06-20
HB107

Regular Session

Relating to the establishment of the sickle cell disease registry.

Government Affairs & Regulatory Compliance Analysis

Business Impact

Who HB107 Affects

Regulatory Priority: moderate

Notable regulatory updates (effective 2025-06-20). Consider how these changes may affect your operations.

Estimated Cost Impact

Need Government Relations Support?

JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.

Need Help Navigating This Legislation?

JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.

01

Compliance Analysis

Key implementation requirements and action items for compliance with this legislation

Immediate Action Plan

Operational Changes Required

Strategic Ambiguities & Considerations

Need Compliance Guidance on This Legislation?

Schedule a Consultation

Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.

02
03
Quick Reference

Frequently Asked Questions

Common questions about HB107

Q

What does Texas HB107 do?

The Texas Legislature has mandated the creation of a statewide Sickle Cell Disease Registry, applicable to all hospitals and diagnostic facilities treating the condition. Unlike standard infectious disease reporting, this statute strictly requires patient consent prior to data submission. Facilities must immediately overhaul intake workflows to prevent unauthorized automated reporting, which would constitute a violation of state privacy law.

Q

Who authored HB107?

HB107 was authored by Texas Representative Lauren Ashley Simmons during the Regular Session.

Q

When was HB107 signed into law?

HB107 was signed into law by Governor Greg Abbott on June 20, 2025.

Q

Which agencies enforce HB107?

HB107 is enforced by Department of State Health Services (DSHS) and Health and Human Services Commission (HHSC).

Q

How significant are the changes in HB107?

The regulatory priority for HB107 is rated as "moderate". Businesses and organizations should review the legislation to understand potential impacts.

Q

What is the cost impact of HB107?

The cost impact of HB107 is estimated as "low". This may vary based on industry and implementation requirements.

Q

What topics does HB107 address?

HB107 addresses topics including electronic information systems, health, health--other diseases & medical conditions, health & human services commission and state health services, department of.

Q

What are the key dates for HB107?

Key dates for HB107: Effective date is 2025-06-20. Rulemaking: Adopt rules defining data submission formats, patient consent requirements, and opt-out procedures. (As soon as practicable after effective date). Consult with legal counsel regarding applicability.

Q

Which Texas businesses are affected by HB107?

HB107 primarily affects healthcare providers and medical facilities. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.

Legislative data provided by LegiScanLast updated: January 11, 2026